Anatomical and Functional Results of Early or Late Switching from Anti-VEGF to Dexamethasone Implant in Case of Poor Anatomical Response in Naïve Patients with Macular Edema Secondary to Branch Retinal Vein Occlusion
 
Yazarlar (2)
Doç. Dr. Zübeyir YOZGAT Kastamonu Üniversitesi, Türkiye
Mehmed Uğur Işık
Kastamonu Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Seminars in Ophthalmology (Q2)
Dergi ISSN 0882-0538 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 01-2024
Cilt / Sayı / Sayfa 39 / 3 / 242–248 DOI 10.1080/08820538.2024.2310662
Makale Linki https://doi.org/10.1080/08820538.2024.2310662
UAK Araştırma Alanları
Göz Hastalıkları
Özet
PurposeTo compare the outcomes of early or late switching from intravitreal (IV) anti-vascular endothelial growth factor (anti-VEGF) injection to IV Dexamethasone (DEX) implant injection in treatment-naïve patients with macular edema secondary to branch retinal vein occlusion.MethodsThis study included 68 eyes of 68 treatment-naïve BRVO patients who started anti-VEGF treatment. After the loading dose, the patients were divided into two groups: Early DEX group (n:34) (DEX implant treatment started after 3 loading doses) and Late DEX group (n:34) (DEX implant treatment started after 6 months). Visual acuity and examination findings were recorded at baseline, 3rd, 6th, and 12th month follow-ups. Optical coherence tomography data were recorded for central macular subfield thickness assessment.ResultsA total of 30 (44.1%) women and 38 (55.9%) men participated, and the average age was 67.6 ± 6.4 …
Anahtar Kelimeler
Anti-VEGF | bevacizumab | branch retinal vein occlusion | dexamethasone | macular edema | switch